TY - JOUR
T1 - Sellar Xanthogranuloma
T2 - A Quest Based on Nine Cases Assessed with an Anterior Pituitary Provocation Test
AU - Fujio, Shingo
AU - Takajo, Tomoko
AU - Kinoshita, Yasuyuki
AU - Hanaya, Ryosuke
AU - Arimura, Hiroshi
AU - Sugata, Jun
AU - Sugata, Sei
AU - Bohara, Manoj
AU - Hiraki, Tsubasa
AU - Yoshimoto, Koji
AU - Arita, Kazunori
N1 - Funding Information:
Conflict of interest statement: This study was partly financed by Health and Labor Sciences Research Grant on “Research on Intractable Diseases in Japan: Hypothalamo-Pituitary Dysfunction” from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We declare that each of us participated sufficiently in the work to take public responsibility for the content of this article. Moreover, we declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the study reported. Case 2 (Figure 5) was previously published by us in Neurologia Medico-Chirurgica (Tokyo)7 and is republished here with the permission of the editorial office.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/10
Y1 - 2019/10
N2 - Background: Xanthogranuloma is a chronic inflammatory mass characterized by cholesterol crystal deposition, which is rarely seen in the sellar region. The objective of this study is to identify the clinical features and cause of sellar xanthogranulomas. Methods: We retrospectively analyzed manifestation, radiographic, and endocrinologic presentation in 9 patients (7 women and 2 men) whom we had previously treated. Results: The patients were between 26 and 73 years of age (median, 56 years). The chief symptoms were visual symptoms in 3, polyuria in 3, headache in 4, and tiredness in 4 patients. Perimetry found visual field deficit in 6 patients. Anterior pituitary provocation tests disclosed impairment of ≥1 hormone in all patients: growth hormone in 8 patients and adrenocorticotropic hormone–cortisol axis in 8 patients. The lesions were suprasellar in 2 patients, intrasellar in 2 patients, and intrasuprasellar region in 5 patients. Three of the lesions were solid and 6 were single cystic to multicystic. Very low intensity area on T2-weighted magnetic resonance imaging was observed in 4 lesions. Postcontrast study performed in 7 lesions showed enhancement in solid parts or cyst walls. Surgical decompression improved visual disturbance in half of the patients but rarely improved hormonal deficits. Follow-up (median, 47 months) found no recurrence of the lesion. In addition to these 9 cases, we found 2 xanthogranulomatous lesions pathologically associated with ciliated epithelia, which also presented with severe hypopituitarism. Conclusions: Xanthogranuloma seems to be the last stage of the chronic inflammation affecting Rathke cleft cyst or craniopharyngioma presenting with severe anterior pituitary insufficiency.
AB - Background: Xanthogranuloma is a chronic inflammatory mass characterized by cholesterol crystal deposition, which is rarely seen in the sellar region. The objective of this study is to identify the clinical features and cause of sellar xanthogranulomas. Methods: We retrospectively analyzed manifestation, radiographic, and endocrinologic presentation in 9 patients (7 women and 2 men) whom we had previously treated. Results: The patients were between 26 and 73 years of age (median, 56 years). The chief symptoms were visual symptoms in 3, polyuria in 3, headache in 4, and tiredness in 4 patients. Perimetry found visual field deficit in 6 patients. Anterior pituitary provocation tests disclosed impairment of ≥1 hormone in all patients: growth hormone in 8 patients and adrenocorticotropic hormone–cortisol axis in 8 patients. The lesions were suprasellar in 2 patients, intrasellar in 2 patients, and intrasuprasellar region in 5 patients. Three of the lesions were solid and 6 were single cystic to multicystic. Very low intensity area on T2-weighted magnetic resonance imaging was observed in 4 lesions. Postcontrast study performed in 7 lesions showed enhancement in solid parts or cyst walls. Surgical decompression improved visual disturbance in half of the patients but rarely improved hormonal deficits. Follow-up (median, 47 months) found no recurrence of the lesion. In addition to these 9 cases, we found 2 xanthogranulomatous lesions pathologically associated with ciliated epithelia, which also presented with severe hypopituitarism. Conclusions: Xanthogranuloma seems to be the last stage of the chronic inflammation affecting Rathke cleft cyst or craniopharyngioma presenting with severe anterior pituitary insufficiency.
UR - http://www.scopus.com/inward/record.url?scp=85068871289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068871289&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2019.06.021
DO - 10.1016/j.wneu.2019.06.021
M3 - Article
C2 - 31203060
AN - SCOPUS:85068871289
SN - 1878-8750
VL - 130
SP - e150-e159
JO - World Neurosurgery
JF - World Neurosurgery
ER -